Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Joel H Datloff , MD

Dermatology • Vancouver, WA

Active NPI 1477581817 Individual Practitioner Male Practitioner Accepts Medicare assignment
Practice location in NPPES

8614 E Mill Plain Blvd, Suite 400
Vancouver, WA 986642059

Call 3602545267 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

8614 E Mill Plain Blvd
Suite 400

Vancouver, WA 986642059

Telephone 3602545267
Fax 3602546089
Organization at the Same NPPES Address or Phone
Columbia Surgical Specialists, Pllc Facility NPI 1184780884

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Other Listings in Public Data

CMS Doctors and Clinicians lists 1 group name: Dermatology Associates Of Southwest Washington, Pllc. See the list

Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.

Listings do not confirm current availability, employment or a shared ownership network.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File

Medical School

University Of North Texas Hsc, College Of Osteopathic Med

Graduation Year

1982

Medicare patients

694 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $179,314 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $124,947 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

1,495 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$464,647 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $1,207.89 across 55 records.

By nature of payment

  • Food and Beverage: $1,108.89 across 54 records.
  • Education: $99.00 across 1 record.

Reporting-company totals (3 largest of 11)

  • Janssen Pharmaceuticals, Inc: $359.25 across 13 records.
  • UCB, Inc.: $300.81 across 13 records.
  • ABBVIE INC.: $186.43 across 9 records.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

44 years (graduated 1982)

CMS Doctors and Clinicians data list 1982 as the year this clinician finished professional school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File.

NPI first issued

2006

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

No telehealth indicator

CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Datloff has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Datloff as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Vancouver and Washington

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 90% of clinicians listed under Dermatology in Vancouver, WA (2024, 14 clinicians with data). Median for this group: 1,578. Middle half: 919 to 2,613.

More Medicare Part B services than 70% of clinicians listed under Dermatology in Washington (2024, 244 clinicians with data). Median for this group: 1,749. Middle half: 802 to 3,541.

Medicare-allowed amount

A higher Medicare-allowed amount than 80% of clinicians listed under Dermatology in Vancouver, WA (2024, 14 clinicians with data). Median for this group: $120,097. Middle half: $67,015 to $169,818.

A higher Medicare-allowed amount than 65% of clinicians listed under Dermatology in Washington (2024, 244 clinicians with data). Median for this group: $118,488. Middle half: $57,562 to $224,878.

Paid by Medicare

A higher Medicare payment amount than 80% of clinicians listed under Dermatology in Vancouver, WA (2024, 14 clinicians with data). Median for this group: $84,797. Middle half: $37,569 to $114,855.

A higher Medicare payment amount than 65% of clinicians listed under Dermatology in Washington (2024, 244 clinicians with data). Median for this group: $81,409. Middle half: $39,184 to $154,214.

Medicare Part D prescriptions

More Part D prescriptions than 70% of clinicians listed under Dermatology in Vancouver, WA (2024, 16 clinicians with data). Median for this group: 810. Middle half: 547 to 1,217.

More Part D prescriptions than 85% of clinicians listed under Dermatology in Washington (2024, 278 clinicians with data). Median for this group: 484. Middle half: 214 to 862.

Part D drug cost

A higher Part D drug cost than 85% of clinicians listed under Dermatology in Vancouver, WA (2024, 16 clinicians with data). Median for this group: $143,975. Middle half: $97,352 to $359,840.

A higher Part D drug cost than 85% of clinicians listed under Dermatology in Washington (2024, 278 clinicians with data). Median for this group: $65,882. Middle half: $7,804 to $224,271.

22 active clinicians are listed under Dermatology with a practice address in Vancouver, WA (384 in Washington).

Addresses are self-reported to NPPES and may be out of date.

Telehealth indicator in Vancouver

13.6% of these 22 clinicians have the CMS telehealth indicator.

81.8% of these 22 clinicians are listed by CMS as accepting Medicare assignment.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 55 records totaling $1,207.89.

Manufacturer Payment Nature Product Type Amount ($)
Janssen Pharmaceuticals, Inc
Education
In-kind items and services
TREMFYA General $99.00
UCB, Inc.
Food and Beverage
In-kind items and services
Bimzelx General $31.67
Janssen Pharmaceuticals, Inc
Food and Beverage
In-kind items and services
TREMFYA General $29.88
UCB, Inc.
Food and Beverage
In-kind items and services
Bimzelx General $28.32
UCB, Inc.
Food and Beverage
In-kind items and services
Bimzelx General $27.89
UCB, Inc.
Food and Beverage
In-kind items and services
Bimzelx General $26.66
Janssen Pharmaceuticals, Inc
Food and Beverage
In-kind items and services
TREMFYA General $25.78
UCB, Inc.
Food and Beverage
In-kind items and services
Bimzelx General $25.32
Janssen Pharmaceuticals, Inc
Food and Beverage
In-kind items and services
TREMFYA General $24.43
Galderma Laboratories, L.P.
Food and Beverage
In-kind items and services
NEMLUVIO General $24.43
ABBVIE INC.
Food and Beverage
In-kind items and services
SKYRIZI General $24.32
ABBVIE INC.
Food and Beverage
In-kind items and services
SKYRIZI General $24.27
Galderma Laboratories, L.P.
Food and Beverage
In-kind items and services
NEMLUVIO General $24.26
UCB, Inc.
Food and Beverage
In-kind items and services
Bimzelx General $24.14
Janssen Pharmaceuticals, Inc
Food and Beverage
In-kind items and services
TREMFYA General $24.03
Janssen Pharmaceuticals, Inc
Food and Beverage
In-kind items and services
TREMFYA General $23.98
Janssen Pharmaceuticals, Inc
Food and Beverage
In-kind items and services
TREMFYA General $23.88
ABBVIE INC.
Food and Beverage
In-kind items and services
SKYRIZI General $23.53
UCB, Inc.
Food and Beverage
In-kind items and services
Bimzelx General $23.42
UCB, Inc.
Food and Beverage
In-kind items and services
Bimzelx General $23.42
UCB, Inc.
Food and Beverage
In-kind items and services
Bimzelx General $22.63
Galderma Laboratories, L.P.
Food and Beverage
In-kind items and services
NEMLUVIO General $22.60
UCB, Inc.
Food and Beverage
In-kind items and services
Bimzelx General $22.29
Galderma Laboratories, L.P.
Food and Beverage
In-kind items and services
NEMLUVIO General $22.22
Galderma Laboratories, L.P.
Food and Beverage
In-kind items and services
NEMLUVIO General $22.09

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
17003 Destruction of precancer skin growth, 2-14 growths
1,269 228 $17.14 $7.11
17000 Destruction of precancer skin growth, 1 growth
426 284 $173.12 $56.23
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
408 307 $230.11 $94.68
88305 Pathology examination of tissue using a microscope, intermediate complexity
320 230 $107.09 $37.89
17110 Destruction of skin growth, 1-14 growths
266 220 $292.60 $116.87
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
256 199 $323.88 $132.74
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
91 80 $143.59 $59.25
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
76 19 $5.30 $0.98
J1100 Injection, dexamethasone sodium phosphate, 1 mg
65 11 $9.21 $0.11
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
57 57 $296.76 $116.39
11102 Biopsy of related skin growth, first growth
33 31 $257.29 $93.43
17111 Destruction of skin growth, 15 or more growths
33 25 $341.07 $141.18
17004 Destruction of precancer skin growth, 15 or more growths
32 24 $428.17 $177.38
88304 Pathology examination of tissue using a microscope, moderately low complexity
25 23 $54.26 $12.56
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
25 25 $420.94 $173.04
96372 Injection of drug or substance under skin or into muscle
23 11 $38.50 $15.13

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Triamcinolone Acetonide Triamcinolone Acetonide 174 5,634 $1,524.24 118
Ketoconazole Ketoconazole 163 6,493 $4,656.14 66
Clobetasol Propionate Clobetasol Propionate 122 3,711 $5,288.15 58
Metronidazole Metronidazole 76 2,570 $7,782.79 34
Fluorouracil Fluorouracil 73 2,203 $5,736.90 67
Doxycycline Hyclate Doxycycline Hyclate 56 3,203 $2,676.52 31
Valacyclovir Valacyclovir Hcl 54 1,460 $745.56 24
Hydrocortisone Hydrocortisone 46 1,200 $364.43 27
Betamethasone Diprop Augmented Betamethasone/Propylene Glyc 46 1,292 $1,184.61 20
Clindamycin Phosphate Clindamycin Phosphate 45 1,455 $1,667.82 21
Minoxidil Minoxidil 40 2,830 $528.45 14
Econazole Nitrate Econazole Nitrate 39 1,228 $1,491.40 11
Fluocinonide Fluocinonide 38 1,170 $1,505.15 18
Tretinoin Tretinoin 25 780 $1,783.73 —
Mupirocin Mupirocin 22 615 $248.74 18
Taltz Autoinjector Ixekizumab 21 588 $144,449.91 —
Calcipotriene Calcipotriene 20 715 $3,768.48 —
Ciclopirox Ciclopirox Olamine 20 535 $302.51 —
Cosentyx Sensoready (2 Pens) Secukinumab 19 532 $147,497.57 —
Betamethasone Valerate Betamethasone Valerate 18 486 $502.03 —
Betamethasone Dipropionate Betamethasone Dipropionate 16 680 $726.18 —
Methotrexate Methotrexate Sodium 13 686 $631.91 —
Humira(Cf) Pen Adalimumab 12 336 $81,738.12 —
Dupixent Syringe Dupilumab 12 336 $44,904.48 —
Minocycline Hcl Minocycline Hcl 11 718 $357.90 —

(top 25 shown)

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Dermatology Primary Specialty

NUCC Taxonomy Code: 207N00000X

License # reported to NPPES WA MD00023811

A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Washington State Department of Health Provider Lookup.
Look Up on State Board Site

Additional State Medicaid & Healthcare Payer Identifiers

Medicaid ID
1027416 (WA)

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - DERMATOLOGY

Medicare Enrollment ID

I20091002000612

Enrollment State Jurisdiction

WA

PECOS Control ID

0840293239

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Medicare Group Practice Enrollments

Source: CMS Doctors and Clinicians National Downloadable File

Dermatology Associates Of Southwest Washington, Pllc

8614 E Mill Plain Blvd, Vancouver, WA 986642092

Phone: 3602545267

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

3 listed
Laura Brandt , PA-C

Physician Assistant

NPI 1013997899

Physician Assistant (Certified)

Mary Burnell , PA-C

Physician Assistant

NPI 1124416508

Physician Assistant (Certified)

NPI 1760676910

Doctor of Medicine (M.D.)

Career & Practice History

NPI enumerated June 28, 2006.

No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1477581817
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: June 28, 2006
Last Update: January 03, 2011
Sole Proprietor: No

Other Dermatology Specialists in Vancouver

All Dermatology Specialists in Vancouver

Mailing Address

8614 E Mill Plain Blvd, Suite 400

Vancouver, WA 986642059

Phone: 3602545267

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.